Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality

被引:11
|
作者
You, Amy S. [1 ]
Sim, John J. [2 ]
Kovesdy, Csaba P. [3 ,4 ]
Streja, Elani [1 ,5 ]
Nguyen, Danh V. [6 ]
Brent, Gregory A. [7 ,8 ]
Kalantar-Zadeh, Kamyar [1 ,5 ]
Rhee, Connie M. [1 ]
机构
[1] Univ Calif Irvine, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Sch Med, Orange, CA 92668 USA
[2] Kaiser Permanente Southern Calif, Dept Nephrol, Los Angeles, CA USA
[3] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[4] Memphis Vet Affairs Med Ctr, Nephrol Sect, Memphis, TN USA
[5] Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA USA
[6] Univ Calif Irvine, Div Gen Internal Med, Orange, CA 92668 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
[8] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
incident ESRD; mortality; pre-ESRD prelude; thyroid; transition; QUALITY-OF-LIFE; SUBCLINICAL HYPOTHYROIDISM; NONTHYROIDAL ILLNESS; FUNCTIONAL DISEASE; KIDNEY-DISEASE; HORMONE LEVELS; DOUBLE-BLIND; RISK-FACTOR; HEMODIALYSIS; TRIIODOTHYRONINE;
D O I
10.1093/ndt/gfy289
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Advanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a high prevalence of thyroid dysfunction. Although hypothyroidism is associated with higher death risk in end-stage renal disease (ESRD) patients, no studies have examined whether thyroid status in the pre-ESRD period impacts mortality after dialysis initiation. Methods. Among US veterans with CKD identified from the national Veterans Affairs database that transitioned to dialysis over the period from October 2007 to September 2011, we examined the association of pre-ESRD serum thyrotropin (TSH) levels averaged over the 1-year pre-dialysis ('prelude') period with all-cause mortality in the first year following dialysis initiation. Results. Among 15 335 patients in the 1-year prelude cohort, TSH levels >5.0 mIU/L were associated with higher mortality in expanded case-mix Cox models (reference: TSH 0.5-5.0 mIU/L): adjusted hazard ratio (aHR) [95% confidence interval (CI) 1.20 (1.07-1.33). Similar findings were observed for TSH >5.0 mIU/L and mortality in the 2- and 5-year cohorts: aHRs (95% CI) 1.11 (1.02-1.21) and 1.15 (1.07-1.24), respectively. Analyses of finer gradations of TSH in the 1-year prelude cohort demonstrated that incrementally higher levels >5.0 mIU/L were associated with increasingly higher mortality in expanded case-mix models (reference: TSH 0.5-3.0 mIU/L): aHRs (95% CI) 1.18 (1.04-1.33) and 1.28 (1.03-1.59) for TSH levels >5.0-10.0 mIU/L and >10.0 mIU/L, respectively. In the 2- and 5-year cohorts, mortality associations persisted most strongly for those with TSH >10.0 mIU/L, particularly after laboratory covariate adjustment. Conclusions. Among new ESRD patients, there is a dose-dependent relationship between higher pre-ESRD TSH levels >5.0 mIU/L and post-ESRD mortality. Further studies are needed to determine the impact of TSH reduction with thyroid hormone supplementation in this population.
引用
收藏
页码:2095 / 2104
页数:11
相关论文
共 50 条
  • [11] The association between thyroid function and nutritional status in patients with end-stage renal disease on hemodialysis
    Shehab-Eldin, Walid
    Shaaban, Mohamed Ahmed
    Atia, Mai Abdel Samed
    Zewain, Shimaa Kamal
    [J]. ALEXANDRIA JOURNAL OF MEDICINE, 2020, 56 (01) : 220 - 225
  • [12] Impact of Socioeconomic Status on Incidence of End-Stage Renal Disease and Mortality After Dialysis in Adults With Diabetes
    Ke, Calvin
    Kim, S. Joseph
    Shah, Baiju R.
    Bierman, Arlene S.
    Lipscombe, Lorraine L.
    Feig, Denice S.
    Booth, Gillian L.
    [J]. CANADIAN JOURNAL OF DIABETES, 2019, 43 (07) : 483 - +
  • [13] Dialysis therapy in end-stage renal disease
    Alok Kalia
    [J]. The Indian Journal of Pediatrics, 1999, 66 (2) : 255 - 262
  • [14] Palliative Dialysis in End-Stage Renal Disease
    Trivedi, Disha D.
    [J]. AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2011, 28 (08): : 539 - 542
  • [15] Hypertension, end-stage renal disease and dialysis
    Stein, G
    [J]. DIALYSE 1995, 1996, : 29 - 36
  • [16] END-STAGE RENAL-DISEASE DIALYSIS
    KEMPH, JP
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 1982, 5 (02) : 407 - 417
  • [17] Clinicopathological characteristics of thyroid cancer in patients on dialysis for end-stage renal disease
    Demirer, Asli Nar
    Kemal, Yasemin
    Gursoy, Alptekin
    Sahin, Mustafa
    Tutuncu, Neslihan Bascil
    [J]. THYROID, 2008, 18 (01) : 45 - 50
  • [18] Dialysis therapies for end-stage renal disease
    Gokal, R
    Hutchison, A
    [J]. SEMINARS IN DIALYSIS, 2002, 15 (04) : 220 - 226
  • [19] A clinical nomogram for the prediction of early mortality in elderly patients initiating dialysis for end-stage renal disease
    Masaki Yoshida
    Masanori Otsuka
    Yoshikazu Watanabe
    Takako Harigai
    Noriyuki Sakurai
    Keiko Kobatake
    Hiroaki Yoshida
    Satsuki Kobayashi
    Takayuki Matsumoto
    Tatsuhiko Sakamoto
    Kazue Ueki
    [J]. Renal Replacement Therapy, 6
  • [20] A clinical nomogram for the prediction of early mortality in elderly patients initiating dialysis for end-stage renal disease
    Yoshida, Masaki
    Otsuka, Masanori
    Watanabe, Yoshikazu
    Harigai, Takako
    Sakurai, Noriyuki
    Kobatake, Keiko
    Yoshida, Hiroaki
    Kobayashi, Satsuki
    Matsumoto, Takayuki
    Sakamoto, Tatsuhiko
    Ueki, Kazue
    [J]. RENAL REPLACEMENT THERAPY, 2020, 6 (01)